These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1806136)

  • 1. Effects of platelet-activating factor on lung epithelial permeability in the guinea-pig.
    Macquin-Mavier I; Franco-Montoya ML; Rosso J; Jarreau PH; Meignan M; Harf A
    Pulm Pharmacol; 1991; 4(4):233-8. PubMed ID: 1806136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of inhalation of platelet-activating factor on the pulmonary clearance of 99mTc-DTPA aerosol.
    Mason GR; Peters AM; Myers MJ; Ind PW; Hughes JM
    Am J Respir Crit Care Med; 1995 May; 151(5):1621-4. PubMed ID: 7735622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of ferret trachea in vitro to 99mTc-DTPA and [14C]antipyrine.
    Hanafi Z; Webber SE; Widdicombe JG
    J Appl Physiol (1985); 1994 Sep; 77(3):1263-73. PubMed ID: 7836130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different effect of salbutamol and aminophylline on platelet activating factor-induced plasma exudation into guinea pig tracheal wall and lumen.
    Liu CY; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Sep; 19(3):211-6. PubMed ID: 8921637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo.
    Greiff L; Erjefält I; Erjefält JS; Wollmer P; Sundler F; Persson CG
    Acta Physiol Scand; 1997 Aug; 160(4):387-91. PubMed ID: 9338520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous platelet activating factor does not affect lung epithelial permeability.
    Bloom JW; Quan SF; Halonen M; Witten ML; Lemen RJ; Patton DD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):405-8. PubMed ID: 3326081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of platelet activating factor on formation and composition of airway fluid in the guinea-pig trachea.
    Rogers DF; Alton EW; Aursudkij B; Boschetto P; Dewar A; Barnes PJ
    J Physiol; 1990 Dec; 431():643-58. PubMed ID: 1712848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration.
    Lin CC; Lin CY
    J Asthma; 1997; 34(2):153-60. PubMed ID: 9088302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
    Sakamoto T; Barnes PJ; Chung KF
    Agents Actions; 1993 Sep; 40(1-2):50-6. PubMed ID: 7908496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
    Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE
    Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinins increase respiratory clearance of 99mTc-DTPA. Mechanisms of action.
    Mordelet-Dambrine M; Huchon GJ; Dusser DJ
    Am Rev Respir Dis; 1992 Oct; 146(4):1014-8. PubMed ID: 1416389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.
    Evans TW; Chung KF; Rogers DF; Barnes PJ
    J Appl Physiol (1985); 1987 Aug; 63(2):479-84. PubMed ID: 3115939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxations of guinea-pig isolated trachea induced by platelet-activating factor are epithelial-dependent and are antagonised by WEB 2086.
    Conroy DM; Samhoun MN; Piper PJ
    Eur J Pharmacol; 1990 Sep; 186(2-3):315-8. PubMed ID: 2289533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites.
    Argiolas L; Fabi F; del Basso P
    Br J Pharmacol; 1995 Jan; 114(1):203-9. PubMed ID: 7712019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.
    Masclans JR; Barberà JA; MacNee W; Pavia J; Piera C; Lomeña F; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):529-32. PubMed ID: 8756833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.